Summary

Immunodiagnostics Market Summary

The global immunodiagnostics market size was valued at USD 30.9 billion in 2025 and is projected to grow from USD 32.5 billion in 2026 to USD 48.1 billion by 2033, at a CAGR of 5.8% from 2026 to 2033. North America dominated the market with the largest revenue share of 37.1% in 2025. Immunodiagnostics represents a major segment of the clinical diagnostics industry and encompasses diagnostic tests that use antigen-antibody reactions to detect or quantify disease-associated biomarkers in patient samples.

Market growth is primarily driven by the rising burden of chronic diseases and the growing adoption of high-sensitivity biomarker-based immunodiagnostic testing. Increasing incidences of cardiovascular diseases, cancer, diabetes, autoimmune disorders, neurological diseases, and other chronic conditions are creating sustained demand for sensitive, specific, and scalable diagnostic assays capable of supporting early disease detection, differential diagnosis, disease monitoring, and treatment selection.

Global Immunodiagnostics Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global immunodiagnostics market report based on product, technology, application, end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Reagents & Consumables
• Instruments
• Software & Services
• Technology Outlook (Revenue, USD Billion, 2021 - 2033)
• Chemiluminescence Immunoassay
• Enzyme-Linked Immunosorbent Assay
• Fluorescence Immunoassay
• Rapid Immunochromatographic Assay
• Radioimmunoassay
• Immunoturbidimetry & Nephelometry
• Immunoblot Assay
• Other Technologies
• Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Infectious Disease Testing
• Oncology Testing
• Cardiac Testing
• Endocrinology Testing
• Autoimmune Disease Testing
• Allergy Testing
• Women’s Health & Reproductive Testing
• Bone, Anemia & Nutritional Testing
• Therapeutic Drug Monitoring & Toxicology
• Neurological Testing
• Other Applications
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospitals
• Laboratories
• Others
• Regional Outlook (Revenue, USD Billion; 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Norway
o Denmark
o Sweden
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Infectious Disease Testing
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Global Immunodiagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.3. Global Immunodiagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis

Chapter 4. Global Immunodiagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Immunodiagnostics Market Product Movement Analysis
4.3. Global Immunodiagnostics Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
4.4. Reagents & Consumables
4.4.1. Reagents & Consumables market estimates and forecasts, 2021 - 2033 (USD Billion)
4.5. Instruments
4.5.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Billion)
4.6. Software & Services
4.6.1. Software & Services market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Global Immunodiagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Immunodiagnostics Market Technology Movement Analysis
5.3. Global Immunodiagnostics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Billion)
5.4. Chemiluminescence Immunoassay
5.4.1. Chemiluminescence Immunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.5. Enzyme-Linked Immunosorbent Assay
5.5.1. Enzyme-Linked Immunosorbent Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.6. Fluorescence Immunoassay
5.6.1. Fluorescence Immunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.7. Rapid Immunochromatographic Assay
5.7.1. Rapid Immunochromatographic Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.8. Radioimmunoassay
5.8.1. Radioimmunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.9. Immunoturbidimetry & Nephelometry
5.9.1. Immunoturbidimetry & Nephelometry market estimates and forecasts, 2021 - 2033 (USD Billion)
5.10. Immunoblot Assay
5.10.1. Immunoblot Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.11. Other Technologies
5.11.1. Other Technologies market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Global Immunodiagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Immunodiagnostics Market Application Movement Analysis
6.2.1. Global Immunodiagnostics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Billion)
6.3. Infectious Disease Testing
6.3.1. Infectious Disease Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.4. Oncology Testing
6.4.1. Oncology Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.5. Cardiac Testing
6.5.1. Cardiac Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.6. Endocrinology Testing
6.6.1. Endocrinology Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.7. Autoimmune Disease Testing
6.8. Autoimmune Disease Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.9. Allergy Testing
6.10. Allergy Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.11. Women’s Health & Reproductive Testing
6.12. Women’s Health & Reproductive Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.13. Bone, Anemia & Nutritional Testing
6.13.1. Bone, Anemia & Nutritional Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.14. Therapeutic Drug Monitoring & Toxicology
6.14.1. Therapeutic Drug Monitoring & Toxicology market estimates and forecasts, 2021 - 2033 (USD Billion)
6.15. Neurological Testing
6.15.1. Neurological Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.16. Other Applications
6.16.1. Other Applications market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Global Immunodiagnostics Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Immunodiagnostics Market End-use Movement Analysis
7.2.1. Global Immunodiagnostics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Billion)
7.3. Hospitals & Clinics
7.3.1. Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Billion)
7.4. Diagnostic Laboratories
7.4.1. Diagnostic Laboratories market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5. Blood Banks & Plasma Screening Centers
7.5.1. Blood Banks & Plasma Screening Centers market estimates and forecasts, 2021 - 2033 (USD Billion)
7.6. Home-Care Settings
7.7. Home-Care Settings market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Immunodiagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
8.3.3. Mexico
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement structure
8.3.3.3. Competitive scenario
8.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4. Europe
8.4.1. Germany
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.2. UK
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
8.6.2. Argentina
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Abbott
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Siemens Healthineers
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Beckman Colter, Inc.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. BIOMÉRIEUX
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. DiaSorin S.p.A.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. QuidelOrtho Corporation
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Thermo Fisher Scientific Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Bio-Rad Laboratories, Inc.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 4 Global Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 5 Global Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 6 Global Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 7 North America Immunodiagnostics Market, by region, 2021 - 2033 (USD Billion)
Table 8 North America Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 9 North America Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 10 North America Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 11 North America Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 12 U.S. Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 13 U.S. Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 14 U.S. Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 15 U.S. Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 16 Canada Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 17 Canada Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 18 Canada Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 19 Canada Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 20 Mexico Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 21 Mexico Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 22 Mexico Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 23 Mexico Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 24 Europe Immunodiagnostics Market, by region, 2021 - 2033 (USD Billion)
Table 25 Europe Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 26 Europe Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 27 Europe Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 28 Europe Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 29 UK Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 30 UK Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 31 UK Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 32 UK Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 33 Germany Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 34 Germany Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 35 Germany Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 36 Germany Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 37 France Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 38 France Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 39 France Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 40 France Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 41 Italy Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 42 Italy Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 43 Italy Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 44 Italy Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 45 Spain Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 46 Spain Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 47 Spain Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 48 Spain Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 49 Denmark Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 50 Denmark Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 51 Denmark Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 52 Denmark Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 53 Sweden Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 54 Sweden Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 55 Sweden Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 56 Sweden Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 57 Norway Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 58 Norway Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 59 Norway Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 60 Norway Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 61 Asia Pacific Immunodiagnostics Market, by region, 2021 - 2033 (USD Billion)
Table 62 Asia Pacific Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 63 Asia Pacific Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 64 Asia Pacific Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 65 Asia Pacific Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 66 Japan Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 67 Japan Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 68 Japan Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 69 Japan Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 70 China Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 71 China Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 72 China Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 73 China Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 74 India Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 75 India Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 76 India Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 77 India Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 78 Australia Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 79 Australia Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 80 Australia Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 81 Australia Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 82 South Korea Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 83 South Korea Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 84 South Korea Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 85 South Korea Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 86 Thailand Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 87 Thailand Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 88 Thailand Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 89 Thailand Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 90 Latin America Immunodiagnostics Market, by region, 2021 - 2033 (USD Billion)
Table 91 Latin America Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 92 Latin America Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 93 Latin America Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 94 Latin America Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 95 Brazil Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 96 Brazil Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 97 Brazil Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 98 Brazil Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 99 Argentina Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 100 Argentina Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 101 Argentina Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 102 Argentina Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 103 MEA Immunodiagnostics Market, by region, 2021 - 2033 (USD Billion)
Table 104 MEA Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 105 MEA Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 106 MEA Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 107 MEA Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 108 South Africa Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 109 South Africa Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 110 South Africa Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 111 Saudi Arabia Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 112 Saudi Arabia Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 113 South Africa Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 114 Saudi Arabia Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)
Table 115 UAE Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 116 UAE Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 117 UAE Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 118 Kuwait Immunodiagnostics Market, By Product, 2021 - 2033 (USD Billion)
Table 119 Kuwait Immunodiagnostics Market, By Technology, 2021 - 2033 (USD Billion)
Table 120 Kuwait Immunodiagnostics Market, By Application, 2021 - 2033 (USD Billion)
Table 121 Kuwait Immunodiagnostics Market, By End Use, 2021 - 2033 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Immunodiagnostics Market: Market outlook
Fig. 9 Immunodiagnostics Market: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Immunodiagnostics market driver impact
Fig. 15 Immunodiagnostics market restraint impact
Fig. 16 Immunodiagnostics market strategic initiatives analysis
Fig. 17 Immunodiagnostics market: Product movement analysis
Fig. 18 Immunodiagnostics market: Product outlook and key takeaways
Fig. 19 Instruments & systems market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 20 Reagents & consumables market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 21 Software & Services market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 22 Immunodiagnostics market: Technology movement analysis
Fig. 23 Immunodiagnostics market: Technology outlook and key takeaways
Fig. 24 Chemiluminescence Immunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 25 Enzyme-Linked Immunosorbent Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 26 Fluorescence Immunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 27 Rapid Immunochromatographic Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 28 Radioimmunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 29 Immunoturbidimetry & Nephelometry market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 30 Immunoblot Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 31 Other Technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 32 Immunodiagnostics market: Application movement analysis
Fig. 33 Immunodiagnostics market: Application outlook and key takeaways
Fig. 34 Infectious Disease Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 35 Oncology Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 36 Cardiac Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 37 Endocrinology Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 38 Autoimmune Disease Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 39 Allergy Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 40 Women’s Health & Reproductive Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 41 Bone, Anemia & Nutritional Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 42 Therapeutic Drug Monitoring & Toxicology market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 43 Neurological Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 44 Other Applications market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 45 Immunodiagnostics market: End use movement analysis
Fig. 46 Immunodiagnostics market: End use outlook and key takeaways
Fig. 47 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 48 Hospitals & diagnostic labs market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 49 Pharma & biotech companies market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 50 Home-Care Settings market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 51 market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 52 Global Immunodiagnostics market: Regional movement analysis
Fig. 53 Global Immunodiagnostics market: Regional outlook and key takeaways
Fig. 54 North America market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 55 U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 56 Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 57 Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 58 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 59 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 60 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 61 France market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 62 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 63 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 64 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 65 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 66 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 67 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 68 Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 69 China market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 70 India market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 71 Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 72 Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 73 South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 74 Latin America market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 75 Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 76 Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 77 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 78 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 79 South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 80 UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
Fig. 81 Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)